A. Zumla (London, United Kingdom), A. Skrahina (Minsk Region, Belarus)
Relationship between exposure with drug resistant tuberculosis and developing new resistant cases
A. Vladimirov, I. Chernyayev (Khanty-Mansjisk, Yekaterinburg, Russian Federation)
|   |
Multidrug-resistant strains of M. tuberculosis circulated in penitentiary system in Kyrgyz Republic
I. Jainagul, S. Nurmira, U. Aleonora, A. Almaz (Bishkek, Kyrgyzstan)
| |
Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
G. Hardavella, S. Karabela, N. Rovina, V. Papageorgiou, N. Poulakis (Athens, Greece)
| |
The preliminary results of retrospective study of dst sld for MDR TB cases identified in Romania 2007
C. Marica, M. Tanasescu, O. Moldovan, C. Didilescu, D. I. Chiotan, N. Galie (Bucharest, Romania)
| |
Drug resistance profile of tuberculosis in a university department of pulmonology in tunis
A. Zouaoui, I. Saada, S. Mahmoud, J. Cherif, N. Mehiri, S. Sanai, H. Smadhi, Z. Souissi, M. Osman, H. Zakhama, B. Louzir, J. Daghfous, M. Beji (Tunis, Tunisia)
| |
Evaluation of a line probe assay kit for direct and simultaneous detection of mycobacterium tuberculosis complex and its resistance to rifampin
M. A. Bennani, M. Guermaz, F. Portaels (Oran, Algeria; Antwerp, Belgium)
| |
Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis
T. Morozova, T. Salina (Saratov, Russian Federation)
| |
MDR/XDR-TB treatment outcome
A. Skrahina, H. Hurevich, A. Astrauko, A. Skrahin, L. Surkova (Minsk, Belarus)
| |
The clinical value of intravenous pulse therapy in first retreatment pulmonary tuberculosis patients
J. Gu, H. P. Xiao, S. J. Tang (shanghai, China)
| |
The experience of complex treatment of XDR-TB patients
I. A. Vasilyeva, V. I. Chukanov, T. R. Bagdasaryan (Moscow, Russian Federation)
| |
Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
M. A. Man, M. Pop, R. Rajnoveanu, A. Todoran, D. Nicolau, D. Homorodeanu (Cluj Napoca, Romania)
| |
Role of surgery in treating of firstly-found destructive pulmonary tuberculosis after ineffective DOTS-therapy
T. Kariev, S. Abulkasimov, S. Sabirov, A. Irgashev (Tashkent, Uzbekistan)
| |
Endobronchial valve application in treatment of drug-resistant lung tuberculosis
A. Levin, Y. Tseimakh, P. Zimonin, A. Samuilenkov, S. Omelchenko, I. Chukanov, S. Lokhmatov, O. Nikolaeva (Barnaul, Russian Federation)
| |
Adjuvant therapy with autologus mesenchymal stem cells in extensively drug-resistant pulmonary tuberculosis. A case study
A. Skrahin, A. Skrahina, S. Krivenko, H. Hurevich (Minsk, Belarus)
| |
Clinical efficacy and safety of clarithromycin in the treatment of multi-drug resistant tuberculosis
S. K. Agarwal, N. Arshad (Varanasi, Gorakhpur, India)
| |
Evaluation of efficacy and safety of linezolid for the treatment of drug-resistant tuberculosis: case series report of 12 patients
M. Anciaes, J. Costeira, J. Pina (Lisbon, Portugal)
| |
Tuberculosis (TB) relapse rate among patients treated with moxifloxacin (m) or ethambutol (E) in the intensive phase of therapy
M. Conde, R. Guerra, M. Cailleaux-Cesar, A. Efron, R. Chaisson (Rio de Janeiro, Brazil; Baltimore, United States Of America)
| |
Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis
P. Baghaei Shiva, M. Marjani, P. Tabarsi, D. Mansouree, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |